Dr Jane Huang welcomes you to the BeiGene booth at the 25th EA virtual congress. She introduces BeiGene's presentations at the congress this year, comprising one oral presentation and 8 posters. These include the latest trials of Zanubrutinib and Tislelizumab across several haematological indications.

Dr Huang outlines the successes of the BeiGene hemtology programme over the past year, and expected approvals in the coming months.